| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0008-1030-06 | 0008-1030 | HUMAN PRESCRIPTION DRUG | Rapamune | SIROLIMUS | SOLUTION | ORAL | 19990901 | 20250131 | NDA | NDA021083 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | SIROLIMUS | 1 mg/mL | 1 CARTON in 1 KIT (0008-1030-06) / 1 BOTTLE, GLASS in 1 CARTON (0008-1030-04) / 60 mL in 1 BOTTLE, GLASS |
| 59762-1205-6 | 59762-1205 | HUMAN PRESCRIPTION DRUG | Sirolimus | sirolimus | SOLUTION | ORAL | 20190722 | N/A | NDA AUTHORIZED GENERIC | NDA021083 | Greenstone LLC | SIROLIMUS | 1 mg/mL | 1 CARTON in 1 KIT (59762-1205-6) / 1 BOTTLE, GLASS in 1 CARTON (59762-1205-4) / 60 mL in 1 BOTTLE, GLASS |